Status:
WITHDRAWN
Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects
Lead Sponsor:
China Medical University, China
Conditions:
Antishivering Effects
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.
Detailed Description
This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.Group Control:traditional intrathecal administr...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status Ⅰ or Ⅱ who were scheduled for elective surgery under spinal anesthesia were enrolled.
Exclusion
- Patients with pre-operative fever (\>38℃), diabetes, , Parkinson's disease, hypo or hyperthyroidism, Raynaud's syndrome, obese patients (weight \>100 kg), patients shorter than 152 cm, those with a history of allergy to the study medications, and patients receiving vasodilators were excluded from the study.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02189655
Start Date
March 1 2016
End Date
December 1 2021
Last Update
November 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Hospital of China Medical University
Shenyang, Liaoning, China, 110001